# Dipeptidyl peptidase‐4 inhibitors and cardiovascular risk: a meta‐analysis of randomized clinical trials

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dipeptidyl-peptidase-4-inhibitors-and-cardiovascular-risk-a-meta-analysis-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matteo Monami,Bo Åhrén,Ilaria Dicembrini,Edoardo Mannucci |
| Citations | 256 |
| DOI | 10.1111/dom.12000 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12000 |
| OpenAlex ID | https://openalex.org/W2157665742 |
| PMID | 22925682 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Matteo Monami](https://scholariq.org/researchers/matteo-monami/)
- [Edoardo Mannucci](https://scholariq.org/researchers/edoardo-mannucci/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.